phenelzine has been researched along with Parkinson Disease in 6 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rojas, RJ | 1 |
| Edmondson, DE | 1 |
| Almos, T | 1 |
| Scott, R | 1 |
| Massari, ME | 1 |
| Hargrave, R | 1 |
| Ashford, JW | 1 |
| Greenberg, R | 1 |
| Meyers, BS | 1 |
| Patni, SK | 1 |
| Dandiya, PC | 2 |
| Hunter, KR | 1 |
| Boakes, AJ | 1 |
| Laurence, DR | 1 |
| Stern, GM | 1 |
| Bhargava, LP | 1 |
6 other studies available for phenelzine and Parkinson Disease
| Article | Year |
|---|---|
Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques.
Topics: Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Small Molecule Libraries | 2015 |
Phenelzine treatment of depression in Parkinson's disease.
Topics: Aged; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa | 1992 |
Treatment of major depression and Parkinson's disease with combined phenelzine and amantadine.
Topics: Aged; Amantadine; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Parkinson Disease; | 1985 |
The influence of monoamine oxidase inhibitors and some other antidepressants on the anti-parkinsonian activity of sub-effective doses of diphenylhydramine in rats and mice.
Topics: Animals; Antidepressive Agents; Catatonia; Diphenhydramine; Humans; Mice; Monoamine Oxidase Inhibito | 1972 |
Monoamine oxidase inhibitors and L-dopa.
Topics: Blood Pressure; Dihydroxyphenylalanine; Drug Synergism; Humans; Hypertension; Male; Middle Aged; Par | 1970 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |